BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 99 found
  Current Search:  fentanyl: 99     

HTML
100%
Clinical Comparison of 12 mg Ropivacaine and 8 mg Bupivacaine, Both with 20 microg Fentanyl, in Spinal Anaesthesia for Major Orthopaedic Surgery in Geriatric Patients
Erturk E et al.

The data showed that 12 mg of ropivacaine and 8 mg of bupivacaine with 20 microg fentanyl in spinal anaesthesia can provide sufficient motor and sensory block for major orthopaedic surgery in geriatric patients.

Clinical Comparison of...

MDLinx:  Feb 8 2010 12:55PM
Matching: fentanyl
Find similar documents
HTML
100%
Surgical tech in Rose hepatitis C case will leave fate to judge
Kristen Parker, the former surgical technician at Denvers Rose Medical Center linked to a wave of hepatitis C infections among patients, told a U.S.

District Court judge Friday that she wants to move forward with a plea agreement she reached earlier while...

San Francisco Business Times:  Feb 8 2010 7:03AM
Matching: fentanyl
Find similar documents
HTML
100%
Research from University of Virginia in the area of granuloma published
- (NewsRx.com) 'As> 95,000 spinal drug-delivery devices have been implanted since their inception in the 1980s, the recognition of associated adverse effects is essential (see also Granuloma).

Since 1985, numerous reports have described the presence of...

Pharmacy Choice:  Feb 8 2010 12:17PM
Matching: fentanyl
Find similar documents
HTML
100%
Gastroenterology: Recent findings from Naval Medical Center, Department of Anesthesiology highlight research in gastroenterology
Today's Medical & Research News Gastroenterology Recent findings from Naval Medical Center, Department of Anesthesiology highlight research in gastroenterology February 8th, 2010 Printer-Friendly Version City:San Diego State:CA Country:United States Abscess...
NewsRX:  Feb 8 2010 5:16AM
Matching: fentanyl
Find similar documents
HTML
100%
Fentanyl Buccal Bests Immediate-Release Oxycodone for Breakthrough Pain Relief: Presented at AAPM
-- Among patients with chronic pain, onset of analgaesia for breakthrough pain (BTP) is faster with oral fentanyl buccal, compared with immediate-release oxycodone, according to a study presented here at the 26th annual meeting of the American Academy of...
PSL Group:  Feb 7 2010 3:46AM
Matching: fentanyl
Find similar documents
HTML
100%
Fentanyl Buccal Bests Immediate-Release Oxycodone for Breakthrough Pain Relief: Presented at AAPM
-- Among patients with chronic pain, onset of analgaesia for breakthrough pain (BTP) is faster with oral fentanyl buccal, compared with immediate-release oxycodone, according to a study presented here at the 26th annual meeting of the American Academy of...
Doctors Guide:  Feb 6 2010 1:19AM
Matching: fentanyl
Find similar documents
HTML
100%
AKELA Pharma Inc. - Financial And Strategic Analysis Review - New Report Published
Newly released report, AKELA Pharma Inc.

- Financial and Strategic Analysis Review, provides detailed company analysis (Companiesandmarkets.com and OfficialWire) LONDON, ENGLAND AKELA Pharma Inc.

- Financial and Strategic Analysis Review Summary The "AKELA...

OfficialWire:  Feb 6 2010 4:19PM
Matching: fentanyl
Find similar documents
HTML
100%
Obstetrics: Stanford University, Department of Anesthesia publishes research in obstetrics
Today's Medical & Research News Obstetrics Stanford University, Department of Anesthesia publishes research in obstetrics February 6th, 2010 Printer-Friendly Version City:Stanford State:California Country:United States Analgesia Analgesic Anesthesia...
NewsRX:  Feb 6 2010 5:03AM
Matching: fentanyl
Find similar documents
HTML
100%
Prostrakan, the Borders-based speciality pharmaceutical group, yesterday said its cancer-pain relief drug Abst
The Galashiels-based company said that the regulatory new drug submission had been made by its Canadian partner, Paladin Labs.

Abstral, which is already marketed in Europe and was accepted for review by the US Food and Drug Administration in October, is a...

Herald Scotland:  Feb 5 2010 3:17PM
Matching: fentanyl
Find similar documents
HTML
100%
TopAbstracts in Pain 02/04/2010
TopAbstracts in Pain are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 7 days.

Over 2000 peer-reviewed journals are covered by...

Doctors Guide:  Feb 5 2010 11:14AM
Matching: fentanyl
Find similar documents
HTML
100%
Akela announces results of legal cases
AUSTIN, TX, Feb.

4 /CNW Telbec/ - Akela (TSX: AKL) a leader in the development of therapeutics for the treatment of pain and its wholly owned subsidiary, PharmaForm, a leader in the contract pharmaceutical development and manufacturing business, today...

Pharma Live:  Feb 4 2010 2:41PM
Matching: fentanyl
Find similar documents
HTML
100%
Akela announces results of legal cases
AUSTIN, TX, Feb.

4 /CNW Telbec/ - Akela (TSX: AKL) a leader in the development of therapeutics for the treatment of pain and its wholly owned subsidiary, PharmaForm, a leader in the contract pharmaceutical development and manufacturing business, today...

Therapeutics Daily:  Feb 4 2010 12:18PM
Matching: fentanyl
Find similar documents
HTML
100%
Paladin Granted Priority Review Status for Abstral by Health Canada
MONTREAL, QUEBEC--(Marketwire - Feb.

4, 2010) - Paladin Labs Inc.

(TSX:PLB), a leading Canadian specialty pharmaceutical company, announced today that it has filed a new drug submission for Abstral sublingual fentanyl.

The submission has been...

Pharma Live:  Feb 4 2010 4:23PM
Matching: fentanyl
Find similar documents
HTML
100%
Paladin Granted Priority Review Status for Abstral(R) by Health Canada
Paladin Labs Inc.

(TSX: PLB), a leading Canadian specialty pharmaceutical company, announced today that it has filed a new drug submission for Abstral(R) sublingual fentanyl.

The submission has been accepted for priority review by Health Canada which...

Genetic Engineering News:  Feb 4 2010 2:27PM
Matching: fentanyl
Find similar documents
HTML
100%
Paladin Granted Priority Review Status for Abstral by Health Canada
MONTREAL, QUEBEC--(Marketwire - Feb.

4, 2010) - Paladin Labs Inc.

(TSX:PLB), a leading Canadian specialty pharmaceutical company, announced today that it has filed a new drug submission for Abstral(R) sublingual fentanyl.

The submission has been...

Therapeutics Daily:  Feb 4 2010 12:52PM
Matching: fentanyl
Find similar documents
HTML
100%
Orexo confirms Canadian Regulatory Filing of Abstral
Orexo AB (STO: ORX) today confirms that its partner, ProStrakan Group plc (LSE: PSK) has announced that the New Drug Submission made by their Canadian partner, Paladin Labs Inc., for AbstralTM has been accepted for review by Health Canada, the Canadian...
Therapeutics Daily:  Feb 4 2010 5:20PM
Matching: fentanyl
Find similar documents
HTML
100%
Orexo confirms Canadian Regulatory Filing of Abstral
- Orexo AB (STO: ORX) today confirms that its partner, ProStrakan Group plc (LSE: PSK) has announced that the New Drug Submission made by their Canadian partner, Paladin Labs Inc., for AbstralTM has been accepted for review by Health Canada, the Canadian...
Pharma Live:  Feb 4 2010 4:22PM
Matching: fentanyl
Find similar documents
HTML
100%
ProStrakan cancer drug up for review in Canada
Prostrakans cancer-pain relief drug Abstral had been accepted for review by Health Canada heraldscotland staff Prostrakan, the Borders-based speciality pharmaceutical group, yesterday said its cancer-pain relief drug Abstral had been accepted for review by...
Herald Scotland:  Feb 4 2010 11:32PM
Matching: fentanyl
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on Wednesday, February 17, 2010
(MARKETWIRE via COMTEX) ----Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the financial markets.

The...

FOXBusiness.com:  Feb 4 2010 1:24PM
Matching: fentanyl
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on Wednesday, February 17, 2010
Companies mentioned in this article: Auxilium Pharmaceuticals, Inc.

MALVERN, PA -- (Marketwire) -- 02/04/10 -- Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year...

Freshnews.com:  Feb 4 2010 12:51PM
Matching: fentanyl
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on
MALVERN, PA--(Marketwire - 02/04/10) - Auxilium Pharmaceuticals, Inc.

(NASDAQ:AUXL - News), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the...

Yahoo! Canada:  Feb 4 2010 12:37PM
Matching: fentanyl
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on Wednesday, February ..
MALVERN, PA -- (Marketwire) -- 02/04/10 -- Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the financial...

PR inside:  Feb 4 2010 12:30PM
Matching: fentanyl
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on Wednesday, February 17, 2010
MALVERN, PA -- (MARKET WIRE) -- 02/04/10 -- Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the...

Street Insider:  Feb 4 2010 12:25PM
Matching: fentanyl
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on Wednesday, February 17, 2010
MALVERN, PA -- (MARKET WIRE) -- 02/04/10 -- Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the...

Street Insider:  Feb 4 2010 12:25PM
Matching: fentanyl
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call
MALVERN, PA -- (Marketwire) -- 02/04/10 -- Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the financial...

PR inside:  Feb 4 2010 12:23PM
Matching: fentanyl
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.